Role of If Density on Electrical Action Potential of Bio-engineered Cardiac Pacemaker: A Simulation Study

Due to the inevitable drawbacks of the implantable electrical pacemaker, the biological pacemaker was believed to be an alternative therapy for heart failure. Previous experimental studies have shown that biological pacemaker could be produced by genetically manipulating non-pacemaking cardiac cells by suppressing the inward rectifier potassium current (IK1) and expressing the hyperpolarization- activated current (If). However, the role of If in such bio-engineered pacemaker is not clear. In this study, we simulated the action potential of biological pacemaker cells by manipulating If-IK1 parameters (i.e., inhibiting IK1 as well as incorporating If) to analyze possible mechanisms by which different If densities control pacemaking action potentials. Our simulation results showed different pacing mechanism between the bioengineered pacemaking cells with and without If. In addition, it was shown that a greater If density might result in a slower pacing frequency, and excessive of it might produce an early-afterdepolarizations-like action potential due to a sudden release of calcium from sarcoplasmic reticulum into the cytoplasm. This study indicated that when IK1 was significantly suppressed, incorporating If may not enhance the pacing ability of biological pacemaker, but lead to abnormal dynamics of intracellular ionic concentration, increasing risks of dysrhythmia in the heart.

[1]  Xiang-Jun Yang,et al.  Mesenchymal stem cells transfected with HCN2 genes by LentiV can be modified to be cardiac pacemaker cells. , 2007, Medical hypotheses.

[2]  M. Takano,et al.  Increased Expression of HCN Channels in the Ventricular Myocardium Contributes to Enhanced Arrhythmicity in Mouse Failing Hearts , 2013, Journal of the American Heart Association.

[3]  Henggui Zhang,et al.  Modelling the effects of chloroquine on KCNJ2-linked short QT syndrome , 2017, Oncotarget.

[4]  T. Schwarz,et al.  The consequences of disrupting cardiac inwardly rectifying K+ current (IK1) as revealed by the targeted deletion of the murine Kir2.1 and Kir2.2 genes , 2001, The Journal of physiology.

[5]  M. Rosen,et al.  The road to biological pacing , 2011, Nature Reviews Cardiology.

[6]  Junyuan Gao,et al.  Human Mesenchymal Stem Cells as a Gene Delivery System to Create Cardiac Pacemakers , 2004, Circulation research.

[7]  Michael R Rosen,et al.  The why, what, how and when of biological pacemakers , 2005, Nature Clinical Practice Cardiovascular Medicine.

[8]  Hiroshi Ito,et al.  Enhancement of Spontaneous Activity by HCN4 Overexpression in Mouse Embryonic Stem Cell-Derived Cardiomyocytes - A Possible Biological Pacemaker , 2015, PloS one.

[9]  Ronald A. Li,et al.  A Singular Role of IK1 Promoting the Development of Cardiac Automaticity during Cardiomyocyte Differentiation by IK1–Induced Activation of Pacemaker Current , 2017, Stem Cell Reviews and Reports.

[10]  H Zhang,et al.  Mathematical models of action potentials in the periphery and center of the rabbit sinoatrial node. , 2000, American journal of physiology. Heart and circulatory physiology.

[11]  Tong Liu,et al.  Computational Analysis of the Action of Chloroquine on Short QT Syndrome Variant 1 and Variant 3 in Human Ventricles , 2018, 2018 40th Annual International Conference of the IEEE Engineering in Medicine and Biology Society (EMBC).

[12]  K. T. ten Tusscher,et al.  Alternans and spiral breakup in a human ventricular tissue model. , 2006, American journal of physiology. Heart and circulatory physiology.

[13]  C. Lau,et al.  Overexpression of HCN-encoded pacemaker current silences bioartificial pacemakers. , 2008, Heart rhythm.